ANTI PLATELET DRUGS





- Tikka (Ticagrelor) in a Can (Cangrelor) → Reversible
- PAR-1 (Protease Activator Receptor) INHIBITOR:
- AtoPaxar
- VoraPaxar


- Aspirin
- Inhibit COX → ↓TXA2
- Clopidogrel, Ticlodipine, Prasugrel
- Reversibly inhibit ADP (P2Y12)
- It is a pro drug
- Irreversible P2Y₁₂ Inhibitors
- Ticagrelor, Cangrelor
- Atopaxar/Vorapaxar
- Act on PAR-1 receptors of thrombin
- Mnemonic: PAR → Paxar

- Abciximab
- Tirofiban
- Eptifibatide
- Act on GP IIb/IIIa
- Mnemonic: 2b3a → ab → Abc, fiban, fibatide ()
ANTI COAGULANTS


These are divided into oral and parenteral anticoagulants.
Oral Anti-Coagulants
- Vitamin K inhibitors
- Direct thrombin inhibitors
- Factor Xa inhibitor
1. Vitamin K inhibitors
- Includes dicumarol and warfarin
Warfarin:
Warfarin
- ⛔Epoxide reductase
- ⇏ Vitamin K active form
- ⛔ gamma carboxylase ⇏ γ carboxyglutamic acid
- Prevent activation of
- 2, 7, 9, 10
- Order of decline (fastest → slowest)
- 7 > 9 > 10 > 2
- Protein C & protein S
- Responsible for Prothrombotic action initial days
- Oral anticoagulant
- Takes 4-5 days to produce action
- Mainly used for maintenance purpose
- Contraindicated in pregnancy →
- Effect of Warfarin is monitored by PT/INR
- Target INR for Post valve replacement: 2.5 - 3.5

Warfarin → Fetal Warfarin Syndrome

- Disala syndrome
- Chondrodysplasia
- Stippled epiphysis
- Nasal hypoplasia
- CNS: Corpus callosum agenesis, microcephaly
- Cataract
- Mnemonic: War (Warfarin) nu poya Michel (Microcephaly) and salar (Disala Syndrome) nu idi kitti mookilum (Nasal hypoplasia) bone (Stipled epiphysis) ilum cartilage (Chondrodysplasia) ilum and killed his cat (Cataract)
Initial Hypercoagulable State
- Seen during first 1–2 days of warfarin therapy
- Causes increased risk of clotting
- Due to protein C deficiency (genetic or functional)
- Leads to:
- Dermal vascular necrosis
- Purple toe syndrome

Warfarin Overdose:
- Overdose of Warfarin causes bleeding.
- For bleeding tendency/warfarin overdose
- Vitamin K is antidote and treatment of choice
- For bleeding
- TOC → Four Factor complex /Prothrombin Factor complex
- Active Factors like IIa, VIIa, IXa, X
- If not available → FFP
- If not available → whole blood
2. Oral Direct Thrombin Inhibitors
Dabigatran
- Can be given Orally
- Does not require monitoring
- Antidote: Idarucizumab
- Mnemonic: Da → Direct acting; Tran → Thrombin antagonist
3. Direct factor Xa inhibitors
- DOAC/NOAC
- Drugs are:
- Rivaroxaban
- RIVAR – REVERSIBLE
- O – ORAL
- XA – XA
- B – BLOCKER (OR)
- AN – ANTAGONIST
- Apixaban
- Edoxaban
- Betrixaban
Injectable Anti-Coagulants
- 1. Indirect Thrombin Inhibitors
- 2. Direct Thrombin Inhibitors
1. Indirect Thrombin Inhibitors [Heparin]
- All activate antithrombin
- UFH
- Inhibit factor IIa = Xa (equal inhibition)
- Mnemonic: Big size → inhibit 2a
- Degraded via Reticuloendothelial system
- Safe in Renal Failure
- LMWH
- Inhibit factor Xa > IIa
- Mnemonic: Lesser size → Less inhibition of 2a
- Preferred for cancer-related thromboembolism
- Fondaparinux
- Only inhibits factor Xa
- Mnemonic: Lowest size → no inhibiton of 2a
- Heparins
- Route → S.C. or IV
- Activate anti-thrombin 3
- Immediate Action → Useful in acute conditions
- Anti-coagulant of choice in pregnancy
- Monitoring done by APTT
- Heparin is always Apt
- Antidote → Protamine Sulphate
Ciraparantag
- Universal reversal agent for anticoagulants
- Antidote for heparin, LMWH, DOACs
- NOT FOR Fondaparinux
- No known drug-drug interactions.
- Safer profile: No anaphylaxis, pulmonary hypertension, or hypotension risks.
- Cira paran → cheera () for parama (universal) problems
WARFARIN vs HEPARIN Table:
Feature | Warfarin | Heparin |
Route | Oral | S/C or IV |
MOA | Inhibit vitamin K | Activate AT – III |
Onset | 4-5 days | Immediate |
Use | Maintenance | Acute condition |
Pregnancy | C/I | DOC |
Monitoring | PT/INR | aPTT |
Antidote | Vitamin K | Protamine Sulphate |
2. Injectible Direct Thrombin Inhibitors (DTI)
- Mnemonic: Din, Tran, Troban
- injectable DTI.
- Bivalirudin
- argatroban
- melagatran
- Troban and Tran → DOC for HIT
- Hirudin and lepirudin are not used now.
ANTIDOTES OF ANTI-COAGULANTS
Antidote vs Anticoagulant Table
Anticoagulant | Antidote | Monitoring |
Warfarin | Vitamin K | PT/INR |
Heparin | Protamine sulfate | aPTT Not required for DOACs, LMWH, Fondaparinux |
Dabigatran | Idarucizumab Mnemonic: Dabbakkullil (Dabi) Idara (idaru) | ㅤ |
Rivaraoxaban or Apixaban | Andexanetalfa Mnemonic: Riverer → and | PT |
Edoxaban | Adexanetalfa Mnemonic: Ed → Ad | ㅤ |
Fibrinolytics/Thrombolytics | EACA > Tranexamic Acid | ㅤ |
FIBRINOLYTIC DRUGS

- Drugs:
- S – Streptokinase
- U – Urokinase
- R – Reteplase
- A – Alteplase
- T – Tenecteplase
- Antidotes:
- Epsilon AminoCaproic Acid [EACA]
- Tranexamic Acid.
- Tissue plasminogen activators.
- tPA → converts plasminogen to plasmin → breaks the thrombus.
- For acute STEMI, acute stroke and acute DVT.
- Overdose of thrombolytics → Leads to bleeding
DRUGS AFFECTING BLOOD CELLS
- Hematinics
- Growth factors
1. HEMATINICS
These are nutritional substances which help in formation of blood. e.g.
- 1. Iron (Fe)
- 2. Folic acid (FA)
- 3. Vitamin B12
Iron Deficiency Anemia
- Treatment of choice is Oral iron.
Oral Iron Therapy (First Line)
- Ferrous sulphate (200 mg):
- Contains 60 mg elemental iron ~10% absorption.
- Absorption increases to ~20% in deficiency.
- Only 6 mg absorbed from a normal dose.
- Ferrous Fumarate
- ferrous gluconate
- Side effect: black stool
- Tabs or drops
- Drops → deep in mouth
- As they cause skin pigmentation.
- Earliest response - Reticulocytosis.
- Adequate response → Hb ↑ by 0.5 g/dl/week
- Factors affecting:
- Ascorbic acid : Increase Absorption
- Phytates, Tannate and oxalates : Decrease Absorption
- Iron deficiency anemia:
- Always continue iron for 3 months after Hb normalizes
- To replenish iron stores
Parenteral Iron therapy
- Ferrous Sucrose (200 mg)
- Ferric Carboxy Maltose
- 1 gm single dose IV
- Iron Isomaltose
- 1 gm single dose IV
Other Preparations of injectable iron are:
- Iron Dextran – Can be given IV as well as IM
- Mnemonic: Dextran → dual route
- Iron Sorbital citrate (Used IM only)
- Mnemonic: Sorbitol → Sirf IM
- IM iron is given by Z-tract technique to avoid pigmentation.
2. HEMATOPOIETIC GROWTH FACTORS
Cells vs Growth Factor vs Drug vs Indications Table
Cells | Growth Factor | Drug | Indications |
RBC | Erythropoietin | Darbopoietin | Anemia due to chronic renal failure Anemia due to bone marrow suppression |
WBC | G-CSF (Granulocyte - stim) GM-CSF (Gra - Mo - Stim) | Filgrastim Sargramostim | Leukopenia due to bone marrow suppression |
Platelets | IL-11 Mnemonic: 11 Plate for OPERA | Oprelvekin (Kin → Interleukin) (oprELEVEkiN → Eleven) Fostamatinib Eltrombopag Romiplostim | Thrombocytopenia due to bone marrow suppression |
- Thrombopoietin receptor agonists - TPO agonists
- Eltrombopag (Oral).
- Romiplostim (Subcutaneous injections).